|
Volumn 45, Issue 5, 2005, Pages 348-353
|
A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
FLUOROURACIL;
GEMCITABINE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
PANCREAS TUMOR;
PHASE 2 CLINICAL TRIAL;
SURVIVAL RATE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DEOXYCYTIDINE;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
SURVIVAL RATE;
|
EID: 32944479671
PISSN: 15989992
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|